Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM

M A Nauck, D Wollschläger, J Werner, J J Holst, C Orskov, W Creutzfeldt, B Willms

284 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM'. Together they form a unique fingerprint.

Medicine & Life Sciences